Translationally controlled tumor protein (TCTP) is implicated in cell growth and malignant transformation. TCTP has been found to interact directly with the third cytoplasmic domain of the a subunit of Na,K-ATPase, but whether this interaction has a role in tumorigenesis is unclear. In this study, we examined TCTP-induced tumor progression signaling networks in human breast epithelial cells, using adenoviral infection. We found that TCTP (a) induces Src release from Na,K-ATPase a subunit and Src activation; (b) phosphorylates tyrosine residues 845, 992, 1086, 1148 and 1173 on anti-epidermal growth factor receptor (EGFR); (c) activates PI3K (phosphatidylinositol 3-kinase )-AKT, Ras-Raf-MEK-ERK1/2, Rac-PAK1/ 2, MKK3/6-p38 and phospholipase C (PLC)-c pathways; (d) enhances NADPH oxidase-dependent reactive oxygen species (ROS) generation; (e) stimulates cytoskeletal remodeling and cell motility and (f) upregulates matrix metalloproteinase (MMP) 3 and 13. These findings suggest that TCTP induces tumorigenesis through distinct multicellular signaling pathways involving Src-dependent EGFR transactivation, ROS generation and MMP expression.
Introduction
Mounting evidence suggests that Na,K-ATPase, known mainly for its role in the maintenance of normal ionic homeostasis, is involved in the activation of different signaling networks associated with cancer and hypertrophy (Xie, 2003; Chen et al., 2006) . For example, abnormal expression or activity of Na,K-ATPase, frequently observed in cancer cells, has been associated with tumor cell progression (Rajasekaran et al., 2001b; Espineda et al., 2003; Barwe et al., 2005) . Conversely, inhibition of Na,K-ATPase by agents such as ouabain induces human cancer cell death (Haux, 1999; Kometiani et al., 2005) . Nevertheless, the exact function of Na,K-ATPase in the molecular mechanisms underlying tumorigenesis is not fully understood.
Partial inhibition of Na,K-ATPase by ouabain promotes Src kinase binding to Na,K-ATPase, with the formation of a signaling complex and transactivation of anti-epidermal growth factor receptor (EGFR), thereby activating different downstream signaling pathways (Haas et al., 2002; Tian et al., 2006) . We previously reported that translationally controlled tumor protein (TCTP) binding to the cytoplasmic domain of Na, K-ATPase a subunit results in the activation of EGFR and its downstream signaling pathways related to cell survival and motility (Jung et al., 2004; Kim et al., 2009) . Thus, it appears that Na,K-ATPase inhibition by TCTP induces Src activation.
Src kinase, containing a negative regulatory domain, can be modulated by changes in its cellular localization. Src is overexpressed or highly activated in a number of human cancers, promoting cancer development (Irby and Yeatman, 2000) . In addition to cell proliferation, Src also regulates other cellular functions, including cell adhesion, motility and invasion, which change the cell behavior, ultimately contributing to the tumor progression and metastasis (Yeatman, 2004) . It has been suggested that direct phosphorylation of the Tyr845 residue of EGFR by Src is a necessary component of Src's role in tumorigenesis (Tice et al., 1999; Ishizawar and Parsons, 2004) . Thus, a downstream signaling pathway activated by Src seems to have an essential role in tumor progression.
TCTP is a highly conserved protein expressed abundantly across a wide range of eukaryotes. TCTP promotes diverse cellular functions by interacting with different proteins, and its expression levels vary depending on the tissue type, growth, stress factors and cytotoxic signals (Nielsen et al., 1998; Teshima et al., 1998; Oikawa et al, 2002) . Knocking down TCTP expression in tumor cells inhibits their growth, motility and invasive functions (Tuynder et al., 2004) . Of interest, TCTP levels are downregulated by activation of the tumor suppressor protein p53 (Tuynder et al., 2002) . As the molecular events linking tumor development to overexpressed TCTP still remain to be fully defined, we examined TCTP-induced tumor progression signaling networks using adenoviral infection in human breast epithelial cells.
Results
Binding of TCTP to the a1 subunit of Na,K-ATPase induces the release and activation of Src Recent studies suggest that phosphatidylinositol 3-kinase (PI3K) binds to the N-terminal proline-rich motif of Na,K-ATPase a subunit and that partial inhibition of Na,K-ATPase by ouabain induces Src binding to the Na,K-ATPase a subunit (Yudowski et al., 2000; Tian et al., 2006) . We found that TCTP bound to the Na, K-ATPase a subunit partially inhibits its pumping activity (Jung et al., 2004) . We therefore thought that conformational changes in the Na,K-ATPase a subunit following its binding to TCTP may affect the binding of PI3K and Src. To test this, we incubated purified Na,K-ATPase a1 with recombinant Src or/and PI3K p85 proteins, following pre-incubation with recombinant human TCTP protein.
The protein complex was then immunoprecipitated with anti-Na,K-ATPase a1 monoclonal antibodies. The binding of PI3K p85 and Src to Na,K-ATPase a1 was significantly decreased following binding to TCTP, suggesting that PI3K and Src, tethered to Na,K-ATPase a1, are released from Na,K-ATPase a1 ( Figure 1a) .
As noted before, the expression level of TCTP tends to be higher in cancer cells than in normal tissues (Tuynder et al., 2002) , and PI3K or Src activation is related to tumorigenesis. We confirmed this in human breast epithelial cells (MCF10A) by overexpressing human TCTP gene using adenovirus. H-Ras-transformed MCF10A cells were also used as a positive control because H-Ras overexpression is known to induce tumorigenesis. Consistent with the above results, both PI3K and Src were tethered to Na,K-ATPase a1 in MCF10A cells (Figure 1b) . However, only Src binding to Na,K-ATPase a1 was significantly decreased in TCTP-overexpressing MCF10A cells. In contrast, both PI3K and Src were dramatically released from Na, K-ATPase a1 in H-Ras-transformed MCF10A cells (Figure 1b) . These results suggest that TCTP binding to Na,K-ATPase a1 causes greater induction of Src release from the a1 subunit than PI3K, in TCTP-overexpressing MCF10A cells. We also examined whether TCTP overexpression stimulates PI3K and Src activation. Activation of both PI3K and Src increased in TCTPoverexpressing MCF10A cells, whereas activation of only PI3K increased in H-Ras-transformed MCF10A cells (Figure 1b) . Taken together, these results suggest that TCTP binding to Na,K-ATPase a1 induces release and activation of Src from the a1 subunit, which in turn stimulates PI3K activation.
TCTP-induced Src activation mediates EGFR transactivation
It has been previously demonstrated that the ouabaininduced Src activation produces a signaling complex and subsequently transactivates EGFR (Tian et al., 2006) . As we found that TCTP binding to Na,K-ATPase a1 induces the release and activation of Src, which is primarily tethered to Na,K-ATPase a1, we tested whether TCTP-induced active Src binds to EGFR and activates the receptor. Co-immunoprecipitation assay using anti-EGFR-specific antibodies under serumstarved conditions showed increased binding of active Src to EGFR in TCTP-overexpressing MCF10A cells (Figure 2a) . The phosphorylation level of EGFR also increased in TCTP-overexpressing MCF10A cells (Figure 2a ). These results suggest that active Src, released from Na,K-ATPase a1 by TCTP, binds to EGFR, causing receptor activation.
As Src-mediated transactivation of EGFR, through the phosphorylation of its Tyr845 residue, is an essential event in breast cancer (Biscardi et al., 2000) , we examined whether TCTP-induced Src activation has any role in EGFR transactivation. We employed the Src-specific inhibitor PP2, SYF (Src-deficient mouse embryonic fibroblast) and SYF þ Src (which constantly express wild-type Src in SYF) cells in this study. TCTPinduced EGFR phosphorylation was significantly binding to Na,K-ATPase. Recombinant human Src, PI3K, TCTP and purified Na,K-ATPase a1 subunit were incubated, immunoprecipitated with anti-Na,K-ATPase a1-specific monoclonal antibodies and then blotted with antibodies described in Materials and methods. (b) Src and PI3K binding to Na,K-ATPase in TCTP-overexpressing MCF10A cells. adNull-and flag-tagged adTCTP-infected cell extracts were immunoprecipitated and blotted as described above.
TCTP-induced Src activation J Jung et al blocked by the Src-specific inhibitor PP2 (Figure 2b) . Phosphorylation of Tyr845 and other tyrosine residues on EGFR also increased in TCTP-overexpressing SYF þ Src cells (Figure 2c ). These results indicate that Src is a key effector molecule in TCTP-induced transactivation of EGFR.
We then investigated whether the TCTP-induced phosphorylation of Tyr845 can induce phosphorylation of other tyrosine residues on EGFR. Phosphorylation of Tyr992, 1086, 1148 and 1173 residues significantly increased in TCTP-overexpressing MCF10A cells (Figure 2d ), but only Tyr1068 phosphorylation increased in H-Rastransformed MCF10A cells. Taken together, these results suggest that Src binding to EGFR and phosphorylation of Tyr845, which subsequently trigger phosphorylation of other tyrosine residues, are essential events in TCTP-induced EGFR transactivation.
TCTP-induced phosphorylation of EGFR stimulates the differential multi-signaling pathway EGFR-mediated signaling is crucial for many cellular processes in breast cancer (Lo et al., 2006) . Also, ouabain-induced activation of EGFR is known to induce different downstream signaling events through binding to adaptor proteins (Haas et al., 2002) . Therefore, we investigated whether TCTP-induced EGFR transactivation stimulates downstream signaling pathways different from those induced by ouabain. Regarding the adaptor proteins binding to EGFR in its transactivation by TCTP-induced active Src, binding of Grb2 increased slightly in TCTP-overexpressing MCF10A cells, whereas it increased remarkably in H-Ras-transformed MCF10A cells (Figure 3a) . Binding of Gab1 and Shc increased only in TCTP-overexpressing MCF10A cells (Figure 3a) , suggesting that TCTPinduced EGFR phosphorylation increases binding of Gab1 and Shc adaptor proteins.
To dissect EGFR downstream signaling pathways associated with tumorigenesis, we next compared TCTP-induced signaling pathways with those induced by H-Ras. In the Ras-Raf-MEK-ERK1/2 signaling pathway, although Ras activity slightly increased in TCTP-overexpressing MCF10A cells compared with that in H-Ras-transformed MCF10A cells, all Rasdependent downstream signaling molecules such as 
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Raf, MEK and ERK1/2 were significantly activated both in TCTP-overexpressing and in H-Ras-transformed MCF10A cells (Figure 3b ). These results suggest that the Ras-Raf-MEK-ERK1/2 signaling pathway functions downstream of TCTP-induced EGFR transactivation. As Rac-MKK3/6-p38 and Rac-PI3K-AKT signaling pathways are essential in H-Ras-transformed MCF10A cells (Shin et al., 2005) , we investigated these pathways in TCTP-overexpressing MCF10A cells also. In the Rac-MKK3/6-p38 signaling pathway, although Rac activity increased more in TCTP-overexpressing MCF10A cells compared with H-Ras-transformed MCF10A cells, MKK3/6 and p38 were more activated in H-Ras-transformed MCF10A cells (Figure 3c ). PI3K and AKT activities in the Rac-PI3K-AKT signaling pathway were similar both in TCTP-overexpressing and in H-Ras-transformed MCF10A cells, despite differences in Rac activity ( Figure 3c ). As PAK is also an essential downstream effector of Rac in cancer signaling networks (Kumar et al., 2006) , we examined whether PAK could be activated by TCTP-induced active Rac. Consistent with the finding on Rac activity, PAK1/2 showed increased activity in TCTP-overexpressing MCF10A cells compared with H-Ras-transformed MCF10A cells (Figure 3c ). These results suggest that TCTP overexpression in MCF10A cells induces the Rac-PAK1/2 signaling pathway to a greater degree than the Rac-MKK3/6-p38 signaling pathway, in contrast to H-Ras-transformed cells.
It is well known that phosphorylation of Tyr992 of EGFR induces phospholipase C (PLC)-g activation. In this study, we demonstrated TCTP-induced phosphorylation of Tyr992 of EGFR in MCF10A cells. We then examined whether PLC-g signaling is regulated by TCTPinduced EGFR transactivation. As shown in Figure 3d , PLC-g was activated both in TCTP-overexpressing and in H-Ras-transformed MCF10A cells (Figure 3d ), suggesting that PLC-g is an essential downstream effector that mediates TCTP-induced EGFR transactivation signaling, as well as H-Ras-related signaling. Taken together, these results suggest that TCTP-induced activation of EGFR causes binding to adaptor proteins, which results in the activation of many different signaling pathways associated with tumorigenesis.
Overexpression of TCTP stimulates reactive oxygen species (ROS) generation from NADPH oxidase through Src and PI3K activation Many human cancer cells generate large amounts of ROS (Szatrowski and Nathan, 1991) . Also, it has been reported that partial inhibition of Na,K-ATPase by ouabain stimulates ROS generation in cardiac myocytes (Liu et al., 2000) . We therefore investigated whether binding of TCTP to Na,K-ATPase stimulates ROS generation in MCF10A cells through TCTP-induced signaling pathways. As shown in Figure 4a , ROS increased 1.7-to 2-fold in TCTP-overexpressing MCF10A cells compared with a 9-fold increase in HRas-transformed cells (Figure 4a ). This suggests that overexpression of TCTP stimulates significant ROS generation in human breast epithelial cells.
To identify the origin of TCTP-induced ROS generation, we compared the effects of treating TCTP-overexpressing MCF10A with those of treating H-Rastransformed MCF10A cells with NADPH oxidasespecific inhibitor (DPI) and/or mitochondria-specific inhibitor (MYX), respectively. DPI and DPI þ MYX, but not MYX alone, significantly blocked TCTPinduced ROS generation in MCF10A cells (Figure 4b) . Interestingly, only MYX and DPI þ MYX blocked ROS generation in H-Ras-transformed MCF10A cells (Figure 4b ). These results suggest that TCTP-induced ROS generation depends on NADPH oxidase in MCF10A cells, and on mitochondria in H-Ras-transformed MCF10A cells.
As ROS generation by growth factor is related to sequential activation of EGFR and PI3K (Park et al., 2004) , and Src has an important role in TCTP-induced EGFR transactivation (as demonstrated in this study), we examined whether TCTP-induced ROS generation depends on Src or PI3K, using Src-and PI3K-specific inhibitors, namely, PP2 and LY294002, respectively. Both PP2 and LY294002 completely blocked TCTPinduced ROS generation in MCF10A. In contrast, only LY294002 showed an inhibitory effect in H-Rastransformed cells (Figure 4c ). Taken together, these results suggest that TCTP-induced ROS generation needs both Src and PI3K activation in MCF10A cells, whereas PI3K activation is essential in H-Ras-transformed MCF10A cells.
Overexpression of TCTP stimulates cytoskeletal changes, cell migration and upregulation of matrix metalloproteinase (MMP) 3 and 13 We recently reported that inhibition of Na,K-ATPase by ouabain results in cytoskeletal remodeling (Jung et al., 2006) . This finding led us to test whether the binding of TCTP to Na,K-ATPase stimulates cytoskeletal remodeling. As shown in Figure 5a , well-developed actin stress fibers and vinculin, a focal adhesion-related protein, were disrupted by the overexpression of TCTP, in MCF10A cells, resulting in the accumulation of actin filaments at the cell periphery patches. This suggests that excessive expression of TCTP stimulates breast epithelial cells to undergo morphological changes characterized by reorganization of cytoskeletal structures and relocation of focal adhesion proteins.
It has been reported that Na,K-ATPase and PI3K influence cell motility in Madin-Darby canine kidney (MDCK) cells (Barwe et al., 2005) . In an earlier study, we showed that PLC-g also influences cell motility in TCTP-overexpressing HeLa cells (Kim et al., 2009) . Here also, we found that Src, PI3K and PLC-g could be activated by TCTP overexpression in MCF10A cells. We therefore examined whether the TCTP-induced activation of Src, PI3K and PLC-g is associated with cell motility. We found that PP2 and LY29002 totally blocked the slight increase in the motility found in TCTP-overexpressing MCF10A cells, but not in H-Ras-transformed MCF10A cells (Figure 5b ). Interestingly, the motility of both TCTP-overexpressing and H-Ras-transformed MCF10A cells was completely blocked by U73122, a PLC-g-specific inhibitor (Figure 5b ). These results suggest that TCTP-induced cell motility is stimulated through Src, PI3K and PLC-g activation and that activation of PLC-g is important in both TCTP-overexpressing and H-Ras-transformed MCF10A cells.
As tumor progression is usually related to MMP expression, the expression levels of MMPs in TCTPoverexpressing MCF10A cells were compared with those in H-Ras-transformed MCF10A cells, using MMP-specific antibodies that were raised against collagenase (MMP-1 and MMP-13), gelatinase (MMP-2 and MMP-9) and stromelysin (MMP-3). Interestingly, only MMP-3 and MMP-13 were upregulated in TCTPoverexpressing MCF10A cells, whereas MMP-2 and MMP-9 were upregulated in H-Ras-transformed MCF10A cells (Figure 5c ). These results suggest that MMP-3 and MMP-13 influence epithelial cell tumor progression more than MMP-2 and MMP-9. Downregulation of TCTP by small interfering RNA (siRNA) attenuates TCTP-induced signaling pathways We found that TCTP induces the activation of Src, EGFR and its downstream signaling pathways.
We examined whether the downregulation of TCTP by siRNA (of overexpressed endogenous TCTP) can restore the interaction of Src with Na,K-ATPase that was disrupted by TCTP in breast cancer cells. We found that the interaction of Src with Na,K-ATPase was in fact significantly restored by the siRNA in MCF10A/ H-Ras, MCF7 and T47D cells (Figure 6a ). We also found that siRNA of TCTP inhibits TCTP-induced transactivation of EGFR and its downstream signaling pathways. The phosphorylations of EGFR, Rac, PI3K, Ras, MKK3/6 and MEK were significantly decreased by siRNA of TCTP (Figure 6b) . It thus appears that downregulation of endogenous TCTP by siRNA attenuates TCTP-induced activation of Src and EGFR, resulting in restraint of its downstream signaling pathways. adNull-and flag-tagged adTCTPinfected MCF10A or H-Ras-transformed MCF10A cells were incubated with 10 mM CM-DCFH for 1 h, and ROS levels were measured by using LSM 510 confocal microscope. Bars, 100 mm. (b) Source of TCTP-induced ROS generation. adNull-and flag-tagged adTCTP-infected MCF10A or H-Ras-transformed MCF10A cells were pre-treated with 20 mM Diphenyleneiodonium (DPI) or 1 mM Myxothiazol (MYX) for 1 h, and the ROS levels were analyzed by flow cytometry. (c) Effect of Src and PI3K on TCTP-induced ROS generation. adNull-and flag-tagged adTCTP-infected MCF10A or H-Ras-transformed MCF10A cells were pre-treated with 10 mM PP2 or with 10 mM LY294002 for 1 h, and the ROS levels were measured as described above. Bars, 100 mm.

Discussion
Recently, it has been suggested that Src interacts with at least two cytoplasmic domains of Na,K-ATPase a subunit, and that this binding keeps Src in its normally inactive form, whereas binding of ouabain to the ectodomain of a subunit changes Src into its active form through a conformational change in the enzyme (Tian et al., 2006) . In the current studies, we showed that Src, apparently tethered to the Na,K-ATPase a subunit, is released and activated by TCTP binding to the a subunit (Figure 1 ) in human breast epithelial cells.
Phosphorylation of Tyr845 of EGFR, leading to physical association between Src and EGFR, is believed to stabilize the activation loop, thereby maintaining the active state of the enzyme and providing a binding surface for substrate proteins (Cooper and Howell, 1993; Biscardi et al., 2000) . Previous reports as well as our current study (Figures 2a-c) suggest that the binding of ouabain or TCTP to the Na,K-ATPase a subunit stimulates Src-mediated EGFR phosphorylation, resulting in phosphorylation of other tyrosine residues on EGFR independent of serum (Haas et al., 2002; Kometiani et al., 2005; Kim et al., 2009) . Phosphorylation of Tyr992 on EGFR has been reported to result in activation of PLC-g-mediated downstream signaling (Emlet et al., 1997) and phosphorylation of a pair of tyrosines 1148 and 1173, providing a docking site for scaffold proteins such as Shc, involved in the MAP kinase signaling pathway (Zwick et al., 1999) . Here, we demonstrated TCTP-induced phosphorylation of Tyr992, Tyr1148 and Tyr1173 of EGFR (Figure 2d ), attraction of adaptor proteins to the phosphorylated EGFR (Figure 3a) , activation of the Ras-Raf-MEK-ERK1/2 pathway ( Figure 3b ) and phosphorylation of PLC-g (Figure 3d ). On the basis of these findings, it appears that Src activation by TCTP binding to Na, K-ATPase a subunit is an essential event in serumindependent transactivation of EGFR. We hypothesize that the phosphorylation of Tyr845 on EGFR by TCTP-induced active Src autophosphorylates other tyrosine residues, thus signaling to various downstream signaling pathways. As TCTP, like ouabain, inhibits Na,K-ATPase, we compared TCTP-induced phosphorylation of EGFR tyrosine residues with those induced by ouabain, and found that ouabain induced phosphorylation of Tyr845, 1086 and 1148, whereas TCTP induced phosphorylation of Tyr992, 1148 and 1173 (Supplementary Figure 1a) . This might explain why the effects of TCTP and ouabain on cell growth are different, although both are Na,KATPase inhibitors.
Rac-MKK3/6-p38 signaling has been shown to be an essential pathway in H-Ras-transformed MCF10A cell motility (Shin et al., 2005) . MKK3/6 and p38 showed greater phosphorylation levels in H-Ras-transformed MCF10A cells than in TCTP-overexpressing cells, in spite of the elevated level of Rac activity in TCTP-overexpressing cells (Figure 3c ). Mounting evidence suggests that PAK, a downstream effector of Rac, is involved in cancer cell signaling networks associated with tumorigenesis and invasiveness (Kumar et al., 2006) . Interestingly, our current study shows greater activation of PAK1/2 in TCTP-overexpressing MCF10A cells than in H-ras-transformed MCF10A cells (Figure 3c ). It thus seems that PAK1/2 is the superior downstream effector of Rac in TCTP-overexpressing MCF10A cells, while MKK3/6-p38 is the one in H-Ras-transformed MCF10A cells.
Although high doses of ROS generated from diverse stimulations are generally cytotoxic, many human cancer cells generate more ROS than normal cells (Szatrowski and Nathan, 1991; Martindale and Holbrook, 2002) . It has been shown that growth factor-induced ROS generation is a result of sequential activation of EGFR, PI3K, bPix, Rac and NOX1 (Bae et al., 1997; Park et al., 2004) . Here, we found remarkable increase in serum-independent, TCTPinduced ROS generation from NADPH oxidase, without cell death (Figures 4a and b) . We also found that the TCTP-induced ROS generation depends upon Src and PI3K activity (Figure 4c ). Therefore, it seems that the TCTP-induced ROS generation is stimulated serum independently by the sequential activation of Src-EGFR-PI3K-Rac-NADPH oxidase in MCF10A cells. In addition, recent reports by us and by others suggest that TCTP upregulates peroxiredoxin in transgenic mice, and that TCTP acts like an antioxidant protein (Gnanasekar and Ramaswamy, 2007; Cheon et al., 2008 ; Nagano-Ito et al., It has been recently suggested that Na,K-ATPase activity is important for the formation of actin stress fibers and junctional complexes in epithelial cells. Also, it has been shown that ouabain rapidly disrupts cytoskeletal structures in HeLa cells (Rajasekaran et al., 2001a; Jung et al., 2006) . In this study, we found that TCTP induces cytoskeletal remodeling and morphological changes, resulting in a loss of tight junctions among others, in MCF10A cells (Figure 5a ). We also observed that TCTP induces increases in cell volume in MCF10A cells, like ouabain does in HeLa cells (Jung et al., 2006) (Supplementary Figure 1b) . We therefore suggest that TCTP induces many different signaling pathways, associated with tumor progression, and triggers cytoskeletal and morphological changes in human epithelial breast cells.
PI3K, PLC-g and Na,K-ATPase have important roles in carcinoma cell motility and invasion (Rajasekaran et al., 2001b; Barwe et al., 2005; Kim et al., 2009) . In this study, we found that U73122 totally blocks TCTP-induced cell motility both in TCTP-overexpressing and in H-Ras-transformed MCF10A cells, in contrast to PP2 and LY294002, which block TCTPinduced cell motility only in TCTP-overexpressing MCF10A cells (Figure 5b ). These results correlate with TCTP-induced ROS generation, as shown in Figure 4c . It thus seems that TCTP-induced ROS generation and cell motility are closely associated.
MMPs are a family of endoproteinases involved in the degradation of the extracellular matrix. Abnormal expression of MMPs contributes to tumor growth, invasion and metastasis (Rowe and Weiss, 2008) . Recent reports suggest that chronic stimulation of ROS upregulates at least four MMPs (MMP-2, MMP-3 and MMP-9, MMP-13), causing tumor initiation and dissemination (Mori et al., 2004) . It has also been reported that MMP-3 and MMP-13 serve as tumor promoters (Sternlicht et al., 2000; Impola et al., 2005) . These reports thus support our findings that overexpression of TCTP triggers ROS generation (Figure 4a) , and upregulates MMP-3 and MMP-13 in MCF10A cells (Figure 5c ).
It has been suggested that several breast tumor cell lines, including MCF-7 and T47D, have a high level of endogenous TCTP, and that siRNA of TCTP or anti-histamines promotes the downregulation of TCTP, resulting in tumor reversion (Tuynder et al., 2002 (Tuynder et al., , 2004 . But the molecular mechanisms in tumor reversion remain to be defined. Here, we found that TCTPinduced chronic activation of Src, EGFR and its downstream signaling molecules associated with cell transformation were significantly downregulated by siRNA of TCTP (Figures 6a and b) . It thus seems that the downregulation of TCTP quenches the activation of tumor-associated signals, causing tumor reversion.
In our present study, we provide insights into TCTP's function as a tumor progression factor. We suggest that TCTP induces Src activation, and thereby multi-signal transduction pathways involving EGFR transactivation, ROS generation as well as MMP upregulation. We explain why overexpression of TCTP is frequently observed in many human cancer cells, and suggest a possible molecular mechanism for tumor progression in human breast epithelial cells.
Materials and methods
Reagents and antibodies
The following were the sources of reagents and antibodies used in this study: purified rat Na,K-ATPase a1 subunit, recombinant human PI3K, Src proteins, anti-Na,K-ATPase a1 subunit and anti-phosphotyrosine (4G10) antibodies were from Upstate (Billerica, MA, USA). Anti-PI3K p85, anti-phospho PI3K p85 (Tyr458)/p55 (Tyr199), anti-protein kinase B (AKT), anti-phospho AKT (Ser473), anti-Src, anti-phospho Src (Tyr416), anti-growth factor receptor-binding protein 2 (Grb2), anti-GRB-associated binder 1 (Gab1), anti-Src homology and collagen (Shc), anti-Raf, anti-phospho Raf (Ser338), anti-MEK, anti-phospho MEK1/2 (Ser217/221), anti-ERK1/2, anti-phospho ERK1/2 (Thr202/ Tyr204), anti-MKK3, anti-phospho MKK3/6 (Ser189/207), anti-p38, anti-phospho p38 (Thr180/Tyr182), anti-Rac, anti-p21 activated kinase (PAK1), anti-phospho PAK1 (Ser199/204)/ PAK2 (Ser192/197), anti-PLC-g, anti-phospho PLC-g (Tyr783), anti-actin, anti-histidine and anti-flag antibodies were from Cell Signaling Technology (Boston, MA, USA). EGFR and anti-H-Ras antibodies were from Santa Cruz (Santa Cruz, CA, USA). Anti-phospho EGFR (Tyr845, Tyr992, Tyr1068, Tyr1086, Tyr1148 and Tyr1173) antibodies were from Invitrogen (Carlsbad, CA, USA). 2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002), 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo [3,4,d] pyrimidine (PP2), 1-[6-[((17b)-3-methoxyestra-1,3,5[10]-trien-17-yl) amino]hexyl]-1H-pyrrole-2,5-dione (U73122), and anti-MMP-1, -2, -3, -9 and -13 antibodies were from Calbiochem (San Diego, CA, USA). Diphenyleneiodonium (DPI) and Myxothiazol (MYX) were from Sigma (St Louis, MO, USA). Anti-vinculin antibody, rhodamine phalloidin, 4 0 ,6-diamidino-2-phenylindole (DAPI) and reduced 5(and 6)-chloromethyl-2 0 ,7 0 -dichlorofluorescein (CM-DCFH) were from Molecular Probe (Carlsbad, MO, USA).
Cell culture, infection and siRNAs for knockdown SYF (Src-deficient mouse embryonic fibroblasts), SYF þ Src (constantly expressing wild-type Src in SYF), MCF10A (human breast epithelial cells) and H-Ras MCF10A (H-Ras-transformed MCF10A) were gifts from Dr Moon (Duksung Women's University, Seoul, Korea). They were cultured as described previously (Jung et al., 2006; Song et al., 2006) . For adenoviral expression, cells were infected with 1 moi/cell of N-terminal flag-tagged TCTP or Null virus for 2 h in Dulbecco's modied Eagle's medium containing 10% serum at 37 1C in 5% CO 2 , followed by a 24-h incubation in Dulbecco's modied Eagle's medium without serum for serum starvation. The construct for intracellular synthesis of TCTP siRNA was made in pSUPER vector (OligoEngine, Seattle, WA, USA) using two oligos, forward (5 0 -GTCCCCAGGTACCGAAAGCACAGTATTC AAGAGATACTGTGCTTTCGGTACCTTTTTTGGAAA-3 0 ) and reverse (5 0 -AGCTTTTCCAAAAAAGGTACCGAAAG CACAGTATCTCTTGAATACTGTGCTTTCGGTACCTG GG-3 0 ). The annealed oligos were cloned into the vector linearized with BalII and HindIII. The functional siRNA corresponding to 5 0 -AGGTACCGAAAGCACAGTA-3 0 of human TCTP gene was synthesized inside mammalian cells transfected with TCTP siRNA construct (Brummelkamp et al., 2002) . Transfection of TCTP siRNA into H-Ras MCF10A/H-Ras, MCF7 and T47D cells were performed by using Lipofectin (WelGENE, Daegu, South Korea). The level of suppression of TCTP gene was determined by western blot analysis.
Co-immunoprecipitation and western blotting Na,K-ATPase a1 subunit purified from rat kidney was incubated with recombinant human Src, PI3K and TCTP in phosphate-buffered saline (PBS) for 1 h at 4 1C. Protein G-agarose-conjugated anti-Na,K-ATPase a1 monoclonal antibodies were then added to the complexes. The bound immune complexes were pelleted, washed thrice with ice-cold PBS, eluted with 2 Â SDS sample buffer and separated on 12% SDS-PAGE. Western blotting and immunoprecipitation of lysates from flag-tagged TCTP-overexpressing cells were performed by using anti-Na,K-ATPase a1, anti-EGFR and protein-specific antibodies.
Ras and Rac GTPase activation assays Ras and Rac GTPase assays were carried out using commercial Ras and Rac activation assay kits (Upstate). Briefly, MCF10A cells infected with null adenovirus (ad Null) or ad TCTP were lysed in ice-cold lysis buffer (MLB) containing Mg 2 þ , 25 mM HEPES (pH 7.5), 150 mM NaCl, 1% NP-40, 0.25% sodium deoxycholate, 10% glycerol, 25 mM NaF, 10 mM MgCl 2 , 1 mM EDTA, 1 mM Na 3 VO 4 , 10 mg/ml aprotinin and 10 mg/ml leupeptin. Active Ras and Rac were then affinity precipitated by adding the Raf-1 or PAK-1 agarose to the cell lysates (1 mg/ml) for 45 min at 4 1C with gentle agitation. After washing thrice with MLB, the agarose beads were pelleted at 10 000 Â g for 10 s at 4 1C, eluted with 2 Â SDS sample buffer, separated on 15% SDS-PAGE, and probed with anti-Ras and -Rac antibodies.
ROS generation
All ROS studies were basically preformed as previously described (Dolado et al., 2007) . adNull-or flag-tagged adTCTP-infected MCF10A cells were incubated with 20 mM DPI, 1 mM MYX, 10 mM PP2 or 10 mM LY294002 for 1 h, washed with PBS and incubated with 10 mM CM-DCFH PBS supplemented with 5.5 mM glucose. After an additional 10-min incubation with pre-warmed (to 37 1C) culture medium, the cells were washed once again with PBS and fixed in 3.7% formalin. The cells were then stained with 1 mM DAPI for staining nuclei and incubated with Image-iTt FX signal enhancer (Molecular Probe) for 30 min. Intracellular ROS levels were visualized and analyzed using laser confocal microscope LSM 510 (Carl Zeiss, Thornwood, NY, USA). For ROS quantification, the cells treated as described above were trypsinized and analyzed by flow cytometry.
Immunofluorescence studies MCF10A cells cultured on an 18-mm f cover glass were infected with adNull or flag-tagged adTCTP adenovirus and serum-starved for 24 h. The cells were then fixed in 3.7% formaldehyde for 10 min at room temperature or in 100% methanol for 1 min at À20 1C, incubated with Image-iTt FX signal enhancer (Molecular Probe) for 30 min and then with rhodamine phalloidin (Molecular Probe) for 30 min. This was followed by incubation with anti-vinculin FITC-conjugated antibodies for 30 min. The cells were then stained with DAPI as a counterstain, mounted in Slow Fade solution (Molecular Probe) and analyzed in laser confocal microscope LSM 510 (Carl Zeiss).
Cell migration and invasion assay Cell migration was measured using CytoselectTM 24-Well Cell Migration Assay kit from Cell Biolabs (San Diego, CA, USA). MCF10A cells cultured in 100 mm 2 dishes were infected with adNull or flag-tagged adTCTP. After 24 h, 300 ml of infected cells (1.0 Â 10 5 cells/ml) was seeded onto the upper chamber of a 24-well migration plate in serum-free media containing 10 mM PP2, 10 mM LY294002 or 10 mM U73122. In the lower well of the chamber, 500 ml of media containing 10% fetal bovine serum was added. After 18 h, the interior of the upper chamber membrane was gently cleaned with cotton swab to remove non-migratory cells, and the lower surface was fixed with 10% formalin/ phosphate and stained with 0.1% crystal violet/20% methanol for 20 min. Cell migration was analyzed using the confocal microscope LSM 510 (Carl Zeiss) and quantified by computerassisted imaging. The average density of migrated cells/4 fields was ascertained.
